ent-Aprepitant-13C15N2 |
|
| Synonyms: 5-[[(2S,3R)-2-[(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one-13C15N2; [2S-[2a(R*),3a]]-5-[[2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one-13C15N2; | |
| Cat. No.: A66261 | CAS No.: Unlabelled: 170729-80-3 |
| MDL.: | Formula: C2213CH21F7N215N2O3 |
| F.W.537.4 | Purity: 99％ |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 10mg | $14500.00 | Enter qty and click checkbox |
 
|
$14500.00 |
| Catalog Number： | A66261 | CAS No.: | Unlabelled: 170729-80-3 | |
| MDL: | Formula: | C2213CH21F7N215N2O3 | ||
| F.W.: | 537.4 | Purity: | 99％ | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | No Data Available | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Chawla, S., et al.: Cancer, 97, 2290 (2003), Huskey, S., et al.: Drug Metab. Dispos., 31, 785 (2003), Warr, D., et al.: Eur. J. Cancer, 41, 1278 (2005), | |||
| Application: | Isotope Labelled (S,R,S)-enantiomer of Aprepitant , an unwanted enantiomer of Aprepitant in bulk drug and formulation samples of Aprepitant. | |||
| Category: | Chiral Reagents, Heterocycles, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, | |||